^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ulocuplumab (BMS-936564)

    i
    Company:
    BMS
    Drug class:
    CXCR4 antagonist
    Related drugs:
    Apply
    Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT01359657)
    Phase 1b
    Bristol-Myers Squibb
    Completed
    Last update posted :
    03/16/2016
    Initiation :
    09/01/2011
    Primary completion :
    03/01/2016
    Completion :
    03/01/2016
    CXCL12
    |
    lenalidomide • bortezomib • dexamethasone • ulocuplumab (BMS-936564)